397. Long-term Mortality of HIV Patients Following Cryptococcal Infection
Session: Poster Abstract Session: Fungal Disease: Management and Outcomes
Thursday, October 4, 2018
Room: S Poster Hall
  • IDweekPosterV6.pdf (858.5 kB)
  • Background: Prevalence of cryptococcosis in HIV-positive patients in the developed world has decreased considerably in the modern anti-retroviral (ART) era. While early mortality of cryptococcal infection is lower than in non-HIV infected patients, late mortality in HIV+ patients has not been previously evaluated. Here, we describe the presentation and outcomes of HIV+ patients with cryptococcosis.

    Methods: We conducted a retrospective cohort study of patients with HIV infection and cryptococcosis from January 2002 to June 2017 at our institution. Data included demographics, clinical features, diagnostics, and outcomes. Death date was obtained from the hospital system’s Medical Informatics database and the Social Security Death Index.

    Results: We reviewed 105 HIV+ patients with cryptococcosis. At time of analysis: 55 were living (52.4%), 17 died within 90 days of cryptococcal diagnosis (early mortality, 16.2%), and 33 died after 90 days (late mortality, 31.4%) (Figure 1). Late mortality patients were more likely to have known HIV+ status at time of cryptococcal diagnosis (97%) than living (70.9%) or early mortality (70.6%) (p=0.03); less likely to be ART adherent (15.2%) than living (43.6%) or early mortality (35.3%) (p=0.02); less likely to have private insurance (6.1%) than living (34.5%) or early mortality (17.6%) (p=0.007); and more likely to have Medicaid (51.5%) than living (29.1%) or early mortality (17.6%) (p=0.03). Presenting symptoms and diagnostics were similar between groups. Prevalence of substance abuse (48.6%) and psychiatric history (31.4%) were high in all groups but not significantly different.

    Conclusion: Despite improvements in ART, HIV+ patients have high mortality following cryptococcal infection which persists beyond their initial hospitalization. Identifying patients at higher risk for mortality is critical for successful treatment and outcomes. In our study, non-adherence to ART was associated with a higher risk of dying. Follow-up studies of late mortality in other opportunistic infections would be beneficial.

    Figure 1. Kaplan-Meier curve of 105 patients with HIV and cryptococcosis. Overall mortality of 47.6% at 5000 days with 17 patients dying in first 90 days (16.2%) and 33 patients dying after 90 days (31.4%).


    Matthew Hevey, MD, Internal Medicine, Division of Infectious Diseases, Washington University in St. Louis, St. Louis, MO, Krunal Raval, MD, Infectious Diseases, Barnes Jewish Hospital - Washington University of St. Louis, St. Louis, MO, Rachel Presti, MD, PhD, Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, MO, William Powderly, MD, Washington University School of Medicine, Division of Infectious Diseases, St Louis, MO and Andrej Spec, MD, Infectious Diseases, Barns Jewish Hospital/Washington University in St.Louis, St. Louis, MO


    M. Hevey, None

    K. Raval, None

    R. Presti, None

    W. Powderly, None

    A. Spec, None

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.